Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent c
Harga semasa N6B.MU ialah €220.1 EUR — telah menurun sebanyak -1.68% dalam 24 jam yang lalu. Pantau prestasi harga saham Labcorp dengan lebih dekat pada carta.
Apakah simbol saham Labcorp?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham Labcorp didagangkan di bawah simbol N6B.MU.
Adakah harga saham Labcorp sedang meningkat?▼
Saham N6B.MU telah jatuh sebanyak -3.04% berbanding minggu sebelumnya, penurunan bulanan ialah -5.94%, namun sepanjang tahun lalu Labcorp menunjukkan peningkatan sebanyak +1.9%.
Bilakah tarikh keputusan kewangan seterusnya bagi Labcorp?▼
Labcorp akan mengeluarkan laporan kewangan seterusnya pada Julai 30, 2026.
Bagaimanakah keputusan kewangan Labcorp pada suku lepas?▼
Keputusan kewangan N6B.MU bagi suku terakhir ialah 3.62 EUR sesaham, manakala anggaran ialah 3.5 EUR, menghasilkan kejutan sebanyak +3.42%. Anggaran keputusan bagi suku berikutnya ialah Tiada EUR sesaham.
Adakah Labcorp membayar dividen?▼
Ya, dividen N6B.MU dibayar suku tahunan. Dividen terakhir bagi setiap saham ialah 0.61 EUR. Setakat hari ini, Hasil Dividen (FWD)% ialah 1.12%.
Berapa ramai pekerja yang dimiliki oleh Labcorp?▼
Sehingga Mei 06, 2026, syarikat mempunyai 67,000 pekerja.
Labcorp terletak dalam sektor apa?▼
Labcorp beroperasi dalam sektor Kesihatan & Kesejahteraan.
Bilakah Labcorp menyiapkan split saham?▼
Labcorp tidak mempunyai sebarang split baru-baru ini.
Di manakah ibu pejabat Labcorp?▼
Ibu pejabat Labcorp terletak di Burlington, Amerika Syarikat.